Clinical Trial

Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Evaluate the prognostic correlation between the neutrophil ratio and the ratio of CD4+/CD8+ T cells in patients with advanced non-small cell lung cancer (NSCLC) who receive immunotherapy combined with chemotherapy, with the aim of providing references for clinical treatment.
Trial Details
NCT Number NCT06954259
Lead Sponsor Qiang Xu
Conditions NSCLC (Advanced Non-small Cell Lung Cancer)
Enrollment 272 participants
Start Date 2022-07-01
Primary Completion 2024-06-30 (estimated)
Study Completion 2025-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-01